NIH-funded research R01 grant

New retinal imaging techniques to help treat memory loss in Alzheimer's patients

Official title: Novel Early Retinal Imaging Biomarkers for Treating Later Spatial Memory Loss in Experimental Alzheimer's Disease

Funded at Wayne State University · NIH-11114012 · Data updated 2026-11-12

This study is looking at how changes in the eye can help spot early signs of memory loss in people with Alzheimer's, aiming to find new ways to help improve thinking skills before major problems arise.

More s Disease research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionWayne State University
NIH-funded
Lab location1 site (Detroit, United States)
Project startSeptember 15, 2023
Project endMay 31, 2028
Funding year2025
Award (this year)$1,064,476
NIH project number5R01AG081981-03
Project IDNIH-11114012 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals at risk for Alzheimer's disease or those in the early stages of cognitive decline.

Less likely to help

Patients with advanced Alzheimer's disease or those without any cognitive impairment may not benefit from this research.

What this research studies

This research investigates how early changes in the retina can serve as biomarkers for cognitive decline in Alzheimer's disease. By examining the retina, which shows similar damage to the brain, researchers aim to identify signs of Alzheimer's before significant cognitive impairment occurs. The study will explore the relationship between retinal health and memory loss, potentially using innovative imaging techniques to assess these changes. This approach could lead to new treatment strategies that focus on restoring cognitive function without necessarily targeting amyloid plaques.

Why it matters

Potential benefit: If successful, this research could lead to earlier detection and more effective treatments for memory loss in Alzheimer's patients.

How similar studies have gone: Previous research has shown promise in using retinal biomarkers to assess cognitive decline, suggesting that this approach could be a viable method for early intervention.

Where this research is happening

  • Wayne State University
    Detroit, United States
    Active

Researchers

  • Principal investigator: Berkowitz, Bruce a. — Wayne State University
  • Study coordinator: Berkowitz, Bruce a.

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.